Which arm workout best helps heart failure patients with implants?

NCT ID NCT07592494

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now This study
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jul 31, 2026 · Updated 1 time

Summary

This study tests different arm exercise routines in 36 adults with heart failure who have an implanted heart device (ICD or CRT). The goal is to see which type of arm workout best improves arm function and overall fitness. Participants will do either high-intensity interval or moderate continuous arm exercises, and their progress will be measured with arm and bike tests.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 36 people

The number the study aims to enrol. It can still change while the study runs.

Started

May 2026

Expected to finish

May 2027

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Patients aged 18 and over with heart failure who are receiving Implantable Cardioverter Defibrillator (ICD) or Cardiac Resynchronization Therapy (CRT) * At least 3 months have passed since device implantation and there have been no complications at the last device control * Being in New York Heart Association (NYHA) Class II-III * Patients without cooperation problems * Patients who volunteer to participate in the study Exclusion Criteria: * Patients who have previously participated in a cardiac rehabilitation program and those who have completed less than 1 year since the program, * Patients with a primary diagnosis of cardiomyopathy and those with heart failure secondary to cardiomyopathy, * Patients with a history of shoulder pathologies that may restrict upper extremity movement before device implantation (such as severe pain around the shoulder, edema, or shoulder dislocation that restricts upper extremity movement), * Patients with a history of shoulder surgery (patients with limitations in range of motion), * Patients who have undergone mastectomy on the affected side or a cerebrovascular event resulting in arm involvement, * Patients with decompensated heart failure, * Patients with a history of ICD-incompatible shock, * Patients with a history of unstable angina pectoris, acute myocardial infarction, or cardiac surgery within the last 3 months, * Patients who have experienced acute atrial fibrillation, ventricular tachycardia, and ventricular fibrillation within the last 3 months, * Patients with actively treated malignancy or collagen tissue disease receiving systemic steroids * Patients with chronic kidney disease undergoing dialysis where volume load is unstable, * Persistent ventricular arrhythmias during baseline cardiopulmonary exercise testing.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Cardiac resynchronization therapy devices are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    1 site. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Hitit University Erol Olcok Training and Research Hospital, Cardiac Rehabilitation Unit

    RECRUITING

    Çorum, Turkey (Türkiye)

More trials for these conditions

Other studies related to the condition(s) this trial covers.